Glucagon-like Peptide-1 Metabolism in the Setting of Acute Neprilysin Inhibition
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2019
Price : $35 *
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Valsartan (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 Jul 2019 Status changed from recruiting to suspended.
- 19 Jun 2018 Status changed from not yet recruiting to recruiting.
- 02 May 2018 New trial record